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ABSTRACT: 
Populations around the world are aging rapidly. Age-related loss of physiological functions 
negatively affects quality of life. A major contributor to the frailty syndrome of aging is loss 
of skeletal muscle. In this study we assessed the skeletal muscle biopsy metabolome of 
healthy young, healthy older and frail older subjects to determine the effect of age and frailty 
on the metabolic signature of skeletal muscle tissue. In addition, the effects of prolonged 
whole-body resistance-type exercise training on the muscle metabolome of older subjects 
were examined. The baseline metabolome was measured in muscle biopsies collected from 30 
young, 66 healthy older subjects and 43 frail older subjects. Follow-up samples from frail 
older (24 samples) and healthy older subjects (38 samples) were collected after 6 months of 
prolonged resistance-type exercise training. Young subjects were included as a reference 
group. Primary differences in skeletal muscle metabolite levels between young and healthy 
older subjects were related to mitochondrial function, muscle fiber type, and tissue turnover. 
Similar differences were observed when comparing frail older subjects with healthy older 
subjects at baseline. Prolonged resistance-type exercise training resulted in an adaptive 
response of amino acid metabolism, especially reflected in branched chain amino acids and 
genes related to tissue remodeling. The effect of exercise training on branched-chain amino 
acid-derived acylcarnitines in older subjects points to a downward shift in branched-chain 
amino acid catabolism upon training. We observed only modest correlations between muscle 
and plasma metabolite levels, which pleads against the use of plasma metabolites as a direct 
read-out of muscle metabolism and stresses the need for direct assessment of metabolites in 
muscle tissue biopsies.  
KEYWORDS: muscle biopsy, frailty, aging, tissue remodeling 
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INTRODUCTION  
Populations around the world are aging rapidly. It has been estimated that people older than 
60 years of age will make up 22% of the world population, whereas people older than 80 
years of age will account for 4.4% of the world population in 2050 
1
. Age-related loss of 
physiological functions compromises independence at older age. A major contributor to the 
frailty syndrome of aging is skeletal muscle loss, which can lead to increased disability in the 
older population. In most people muscle mass and strength start to decline around the age of 
35 with more progressive muscle loss observed after the age of 65 
2-6
. 
Exercise training has been applied to counter the effects muscle mass loss, such as loss of 
strength 
7, 8
. We recently demonstrated that prolonged resistance-type exercise training 
partially shifts the skeletal muscle transcriptome of older subjects toward an expression 
pattern observed in muscle tissue of young subjects, with changes in gene expression related 
to vascularisation, tissue remodelling and glucose metabolism 
9
. The transcriptome analysis 
also revealed substantial differences between healthy young men, healthy older subjects and 
frail older subjects before any intervention was undertaken. In particular, genes related to 
mitochondrial function had lower expression levels in older subjects compared to young 
subjects.  
The age-related differences in gene expression level in muscle are expected to be reflected in 
local levels of metabolites. However, limited information is available on the effect of aging on 
muscle metabolite levels. A recent study in mice showed that aging affects muscle glucose 
and fatty acid metabolism
10
, whereas a study in rats indicated that aging leads to muscle 
group-specific perturbations in lipid and glucose metabolism consistent with mitochondrial 
dysfunction 
11
. In humans, it was found that changes in lipid content and oxidative activity in 
skeletal muscle during aging are related to a shift in muscle fiber type
12
. Interestingly, 
exercise training led to reprogramming of mitochondrial function and intermediary 
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metabolism in insulin-insensitive obese subjects 
13
. In both human studies, the metabolic 
profiling platforms that were used had limited coverage and focused on specific sub-
metabolomes. A major bottleneck in achieving extended coverage has been the limited 
amount of muscle tissue material that can be sampled from human subjects.  
On the basis of the observed shift in transcriptome profiles after training we hypothesized that 
a similar shift towards the young phenotype occurs in the muscle metabolome after resistance-
type exercise training in older subjects. The recent development of a comprehensive targeted 
metabolic profiling platform optimized and validated for small muscle biopsies makes it 
possible to elaborately verify this hypothesis 
14
. Here we aim to investigate the effect of aging 
and frailty on the skeletal muscle metabolome. In addition, we examined the impact of 
prolonged resistance-type exercise training on the metabolome of frail and healthy older 
subjects.  
 
MATERIALS AND METHODS 
Experimental design 
Muscle biopsies (m. vastus lateralis), plasma and serum samples were collected from frail 
older 
15, 16
, healthy older 
17, 18
 and young subjects 
19
. The frail group included both frail and 
pre-frail subjects and are hereafter referred to as frail. Medical history of all subjects was 
evaluated by medical questionnaires, which were analyzed by a physician. Subjects who were 
unable to participate in the exercise program due to pain were excluded prior to starting the 
intervention. Included subjects who showed severe discomfort during the training sessions 
were excluded from further participation in the study. Baseline metabolite levels were 
measured in skeletal muscle tissue of 30 young, 66 healthy and 43 frail older subjects (Table 
1). We also measured metabolites in plasma and serum for 50 young, 76 healthy and 62 frail 
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older subjects (Supporting Information Table S1). The transcriptome of the muscle samples 
was measured in an earlier study 
9
.  
 Baseline samples from healthy young male subjects served as reference and were derived 
from several studies performed within our group, in which exactly the same techniques and 
processing were used for sample collection. Samples from the frail and healthy older subjects 
were obtained from two study centers. More details of the studies can be found in the papers 
published previously 
15, 18
. In addition, muscle biopsies were obtained after 6 months of 
resistance-type exercise training for 38 healthy and 24 frail older subjects. All muscle biopsies 
and blood samples were obtained in the morning after an overnight fast. Subjects ate a 
standardized meal the evening before sample collection. Subjects refrained from doing any 
strenuous physical activity for 3 days prior to muscle biopsy collection.  
Fried criteria 
20
 were used to assess the frailty in older subjects, which takes into account 
unintentional weight loss, weakness, self-reported exhaustion, slow walking speed, and low 
physical activity. Based on the above mentioned criteria, the healthy older subjects were not 
considered frail or pre-frail at the start of the intervention study 
21
. 
In our study population, all older subjects regardless of their health status (frail or healthy) 
improved in muscle performance following 6 months of resistance-type exercise training 
(Supporting Information Figure S1 Table S2 ), as illustrated by significantly increased leg 
extension and leg press strength after training (P-value < 0.01) 
9, 15, 21
. Both healthy older and 
frail older subjects followed similar progressive full-body resistance type exercise training. In 
brief, the training consisted of a 5 minute warm-up on a cycle ergometer, followed by 4 sets 
on the leg-press and leg-extension machines. In addition, 3 sets of chest press, lat pulldown, 
pec-dec and vertical row machines were performed (Technogym, Rotterdam, The 
Netherlands). The healthy older subjects trained 3 times per week and frail subjects trained 2 
times per week. Moreover, subjects received a protein or control supplement during the study. 
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Healthy older subjects took 15 gram milk protein or control drink at breakfast and frail older 
subjects took a similar 15 gram drink (milk protein or control) at breakfast and lunch every 
day throughout the entire 6 months intervention. Full details can be found in the earlier papers 
on the phenotypical impact of training on our study population 
15, 21
. All studies were 
approved by The Medical Ethics Committee of either Wageningen University or Maastricht 
University and comply with the Declaration of Helsinki. 
 
Metabolomics analysis of circulating metabolites 
Amino acids and biogenic amines were derivatized (Acc-Tag) in 5 µL aliquots of plasma. 
Samples were analyzed using an ACQUITY UPLC system with autosampler (Waters, Etten-
Leur, The Netherlands) coupled with a Xevo Tandem quadrupole mass spectrometer (Waters) 
operated using QuanLynx data acquisition software (version 4.1; Waters). An Accq-Tag Ultra 
column (Waters) was used. The Xevo TQ was used in the positive-ion electrospray mode and 
all analytes were monitored in Multiple Reaction Monitoring (MRM) using nominal mass 
resolution. Acquired data were evaluated using TargetLynx software (Waters), by integration 
of assigned MRM peaks and normalization using proper internal standards
22
,  
Acylcarnitines, trimethylamine-N-oxide, choline, betaine, deoxycarnitine and carnitine were 
analyzed in 5 µL plasma, spiked with an internal standard, using a UPLC-MS/MS. Also here 
an Accq-Tag Ultra column was used. The Xevo TQ was used in the positive-ion electrospray 
mode and all analytes were monitored in MRM using nominal mass resolution. In-house 
developed algorithms 
23
 were applied using the pooled QC samples to compensate for shifts in 
the sensitivity of the mass spectrometer over the batch. 
Organic acids were measured by GC-MS using 50 µL of plasma sample prepared using a two-
step derivatization procedure with subsequent oximation using methoxyamine hydrochloride 
(MeOX) and silylation using N-Methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA. 
Samples were measured on an Agilent GC (7890A) coupled to Agilent Quadrupole-MS with 
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EI source (Agilent MSD 5975C). Separation was performed using a HP-5MS column (30 m x 
0.25 m x 0.25 µm; Agilent). The raw data were pre-processed using Agilent MassHunter 
Quantitative Analysis software for GC-MS (Agilent, Version B.04.00), and quantitation of 
metabolite response was calculated as the peak area ratios of the target analyte to the 
respective internal standard. In-house developed algorithms were applied using the pooled QC 
samples to compensate for shifts in the sensitivity of the mass spectrometer over the batch. 
Serum metabolite concentrations determined by NMR were measured as described by 
Mihaleva et al 
24
. In short, serum samples were ultrafiltrated and automated quantum 
mechanical line shape fitting of 
1
H NMR spectra was performed using PERCH. 
 
In tissue metabolome analysis 
Metabolites were extracted from 10 mg of wet muscle tissue. This tissue was further 
lyophilized and weighted to determine the dry tissue mass. After pulverizing the tissue, 
metabolites were extracted using methanol/chloroform/water (MCW). The extraction method 
used in this study has extensively been described and characterized elsewhere 
14
.  
Amines, acylcarnitines and oxylipins were measured using the platforms also used for 
measurement of these metabolites in plasma. The validation of these methods for human 
tissue biopsies is described in detail elsewhere 
23
. In-house developed algorithms were applied 
to compensate for shifts in the sensitivity of the mass spectrometer over multiple batches of 
measurements 
23
. The metabolite response was determined by the peak area ratio of the target 
analyte to the appropriate internal standard. These response ratios were used in the subsequent 
data analysis. ATP, ADP, creatine and phosphocreatine were determined using established 
enzymatic assays. For the first 3 metabolites, commercially available fluorimetric assay kits 
were used (BioVision cat.# K354-100, K355-100 and K635-100) following the 
manufacturer’s instructions. Phosphocreatine was measured according to a colorimetric assay 
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kit protocol described by Szas et al.
25
. In total 96 metabolites including amine, acylcarnitines, 
organic acids, oxylipins and a number of nucleotides were measured.  
Statistical analysis 
Statistical analysis was performed on log-transformed data. We used analysis of variance 
(ANOVA) for between group comparisons at baseline. P-value <0.05 was considered 
statistically significant. We used linear mixed models for assessment of the training effect. 
Our model included exercise training, subject, sex, protein supplementation and within 
subject correlation. Analyses of the training effect was performed separately for frail and 
healthy older subjects due to differences in training frequency. To summarize acylcarnitines 
into one single metabolite (eigenmetabolite), the Non-linear Iterative partial least squares 
(NIPALS) algorithm 
26
 of the mixOmics R library was used to calculate the Singular Value 
Decomposition (SVD) of acylcarnitines. To integrate metabolomics and transcriptomics data 
the multilevel sparse partial least squares (sPLS) module from the mixOmics R library was 
used 
27
. We applied canonical correlation ( cut-off => 0.8), which highlights the strongest 
correlations between the two data sets. FactoMineR was used to perform principal component 
analysis (PCA) 
28
. All analyses were done using R (version 3.02).  
ASCA (ANOVA Simultaneous Component Analysis) was performed to determine global 
differences on metabolites. ASCA is a multivariate method that partitions variation in the data 
and enables to interpret these partitions by simultaneous component analysis 
29
. Analysis was 
performed separately for the frail and healthy older subjects, using delta values of each 
metabolite for each individual (value after training - value before training) with supplement, 
sex and their interaction in the model as factors. Analysis was done under Matlab (version 
R2012a). 
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RESULTS 
Baseline comparisons between healthy older, frail older and young subjects 
Comparison of the plasma metabolite profiles of young and healthy older subjects showed 
marked differences in levels of many metabolites between the groups. Analysis of variance 
(ANOVA) showed that differences in plasma metabolite levels between older and young 
subjects were mainly accounted for by the amino acids and acylcarnitines. These differences 
were in line with previous observations of age-related effects on the plasma metabolome 
10, 30, 
31
. 
Figure 1 shows a principal component analysis (PCA) plot of the biogenic amine profiles of 
the muscle biopsies obtained from young, healthy older and frail older subjects, before and 
after exercise. We observed clear age-related differences in the biogenic amine profiles of 
skeletal muscle, as well as a difference between healthy and frail older subjects. The PCA plot 
also revealed an effect of prolonged resistance-type exercise training on amine concentrations 
in muscle tissue. PCA revealed a similar effect for organic acids in muscle (Supporting 
Information Figure S2).  
ANOVA yielded a series of skeletal muscle metabolites that differ significantly between 
healthy older subjects and young subjects. Many of these metabolites are amino acids and 
organic acids (Table 2). The outcome of ANOVA modeling of muscle metabolites in healthy 
vs. frail older subjects is presented in Table 3. 
Effect of prolonged resistance-type exercise training in frail and healthy older subjects 
In the PCA plot in Figure 1 we can observe that prolonged resistance-type exercise training 
has an effect on the biogenic amine profile of skeletal muscle tissue of frail and healthy older 
subjects. The trends in the PCA plot suggest that upon training both healthy and frail older 
subjects shift towards a younger phenotype (see also the plot for the average value of 
isoleucine in Supporting information Figure S3,a). The variation in this PCA plot may not 
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only be due to phenotype (young, healthy and frail old) and exercise, but also to sex and 
protein supplementation. Accordingly, we performed ANOVA Simultaneous Component 
Analysis (ASCA) to account for these different sources of biological variation. We observed 
that prolonged resistance-type exercise training had a weak effect on muscle tissue metabolite 
levels. No significant interaction of protein supplementation with training in both frail and 
healthy older subjects could be observed. Interaction of sex with training was not significant 
in healthy older subjects, but was significant in frail older subjects (P-value=0.03).  
Next we used linear mixed models on univariate metabolite levels to account for phenotype, 
exercise, protein supplementation and sex as sources of biological variation. We observed that 
prolonged resistance-type exercise training affected muscle levels of acylcarnitines in both the 
healthy older and frail older subjects (Table 4 and 5, respectively). These include 
acylcarnitines that are produced during oxidation of branched chain amino acids (propionyl 
(C3), methylmalonyl (C4-DC), and isovaleryl (C5) acylcarnitines) and acylcarnitines that are 
produced during fatty acid oxidation (C6-C20 acylcarnitines) 
32
. Because the exercise effect 
on several acylcarnitines was nearly significant (P-value >0.05), we used the singular value 
decomposition to summarize the levels of fatty acid derived and amino acid derived 
acylcarnitines (denoted as FAAC and AAAC, respectively in Figure 4 and 5). Subsequently, 
we also performed linear mixed model analysis to determine the effect of training on the fatty 
acid derived and amino acid derived acylcarnitines. The amino acid derived acylcarnitines 
levels were significantly decreased after training in both healthy and frail older subjects (see 
example of the effects for propionylcarnitine in Supporting information Figure S3,b).  
We used multilevel sPLS to integrate changes in the muscle transcriptome and muscle 
metabolome after training. Here the goal was to investigate the interaction of two matched 
datasets and the selection of subsets of either positively or negatively correlated variables 
across all subjects. Only those genes were selected that were significantly changed by training 
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(FDR<0.05) in both frail and healthy older subjects. The resulting correlation network in 
Figure 2 shows  that especially branched chain amino acids correlate with genes related to 
connective tissue/extracellular matrix such as collagen, laminin and Secreted Protein, Acidic, 
Cysteine-Rich (SPARC) .  
Correlation between muscle and plasma metabolites levels 
Next we investigated to what extent baseline plasma metabolite levels reflect muscle 
metabolite levels. To that end we first constructed separate correlation heatmaps for muscle 
and plasma metabolites within each compartment. Figure 3a-b shows that metabolites that 
belong to the same group of metabolites (e.g. amino acids, acylcarnitines) are correlated to 
each other, which is observed for both plasma and muscle. However, the heatmap of the 
correlation between muscle and plasma metabolites (Figure 3c) showed only minor to 
moderate correlations (Pearson correlation between 0.3 and 0.5). The correlation networks 
(Figure 3d) revealed the strongest correlations for 3-hydroxybutyric acid, 4-hydroxyproline, 
proline, branched chain amino acids and several acylcarnitines. Correlations between serum 
and muscle metabolites are presented in Supporting Information Figure S4. The results are 
generally similar to the correlations observed between plasma and muscle metabolites. 
DISCUSSION 
Comprehensive metabolic profiling of muscle biopsies: differences with age and effect of 
resistance-type exercise training in a heterogeneous study population 
 
Comprehensive metabolic profiling of muscle biopsies revealed pronounced differences 
between the muscle biopsy metabolomes of healthy young, healthy older and frail older 
subjects. Furthermore, distinct effects of prolonged resistance-type exercise training could be 
observed in both groups of older subjects..  
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A key asset of our analysis was the deployment of five robust profiling platforms using a 
single and thoroughly validated muscle-biopsy extraction procedure 
14
. The analytical 
variation in these profiles was around 20-30%, which was smaller than the biological 
variation between the muscle biopsies. In order to separate the sources of biological variation 
in our heterogeneous study population, we used univariate linear mixed models. Interestingly, 
the metabolic effects of supplementation and differences between males and females were 
relatively minor compared to the differences between old and young and between healthy and 
frail. The effects were also minor compared to the response to prolonged resistance-type 
exercise training. A multivariate approach (ASCA) did not show any significant effects of 
training, probably because not all sources of biological variation could be adequately 
accounted for 
33
. In the following discussion we focus on the univariate linear mixed model 
approach since it allows us to more precisely account for protein supplementation and sex in 
our study population.  
 Baseline comparisons 
Interestingly, in muscle biopsies baseline levels of metabolites from the tricarboxylic acid 
cycle (succinic acid, fumaric acid, 2-ketoglutaric acid) were lower in the healthy older 
subjects compared to young subjects. These differences were accompanied by lower levels of 
ATP, ADP, branched chain amino acids and acylcarnitines in the healthy older subjects, 
suggesting impaired mitochondrial function or a lower number of mitochondria in the muscle 
of the older subjects, which in turn may be a consequence of the lower habitual physical 
activity of the older subjects. These observations are in line with data on the muscle 
transcriptomic profiles of these subjects, which show decreased expression of genes related to 
mitochondrial function and oxidative phosphorylation in the older subjects compared to 
young subjects, with the lowest expression observed in the frail older subjects 
9
. These 
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findings are in agreement with other studies 
10, 34-38
, which also showed a down-regulation of 
the mitochondrial electron-transport chain pathway in older as compared to young subjects.  
One of our findings is that levels of 4-hydroxyproline and proline are lower in the healthy 
older subjects compared to the young subjects. Both of these amino acids have been 
associated with collagen turnover 
39, 40
. Muscle levels of two precursors of proline, ornithine 
and arginine, are higher in the older subjects, which together with lower levels of 4-
hydroxyproline and proline may be due to dysfunction of the mitochondrial ornithine 
aminotransferase 
41
, leading to accumulation of arginine and ornithine. This notion is in line 
with slightly lower expression of genes related to tissue remodeling, such as collagen in the 
older subjects compared to the young subjects 
9
.  
We observed higher levels of β-isoamino butyric acid (BAIBA) in muscle tissue of healthy 
older subjects compared to  young subjects. This metabolite has been suggested to be 
produced upon exercise by expression of PGC-1α and has been proposed as a myokine 
stimulating browning of white adipose tissue and hepatic β-oxidation 
42
. In our study 
population we observed lower expression of PGC-1α target genes in healthy older subjects 
compared to young subjects, and in frail older subjects compared to healthy older subjects 
9
. 
The activity of PGC-1α is modulated post-translationally by NAD
+
 dependent deacetyltation 
by SIRT1 (Figure 4-b) 
43
. Since NAD
+
 levels decrease with age 
44
, we expect a concurrent 
downregulation of PGC-1α 
45
. However, lower levels of BAIBA were only observed when 
comparing frail to healthy older subjects, whereas BAIBA levels were higher in healthy older 
subjects compared to young subjects. Assuming that aging lead to down-regulation of PGC-
1α, the observed changes in baseline muscle BAIBA levels are not consistent with BAIBA 
serving as a marker for PGC-1α activity. Thus, we cannot confirm the notion that BAIBA acts 
as a PGC-1α induced myokine. A possible explanation for the discrepancy is that in our study 
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differences in PGC-1α expression are caused by age and frailty-dependent processes, whereas 
previously described PGC-1α -mediated effects on BAIBA were caused by acute exercise.  
Two polyamines, spermine and spermidine, were found to be significantly different between 
the frail in comparison to the healthy older subjects. Polyamines are involved in tissue 
regeneration and cell proliferation and differences are associated with both exercise and 
muscle pathology 
46-48
. The genes directly involved in the polyamine pathway are however 
not differentially expressed between frail and healthy older subjects. Hence the observed 
differences in polyamine levels between the frail and healthy older subjects are more likely to 
be attributed to effects at the level of enzyme activity or metabolite transport. Previous studies 
have shown that perturbations in polyamine metabolism are associated with neuromuscular 
disorders 
49, 50
. On the transcriptome level we indeed found indications of neuromuscular 
perturbations in the frail older subjects 
9
. In addition, increased spermine levels were recently 
linked to skeletal muscle atrophy 
51
. However, we observed lower levels of spermine in frail 
subjects in comparison to healthy older subjects, even though frail older subjects generally 
have less skeletal muscle and are likely to exhibit more extensive muscle atrophy. Ost et al. 
recently reported that spermidine is increased in the skeletal muscle of mice overexpressing 
uncoupling protein 1. The authors proposed that this might be an adaptive response to cope 
with the additional oxidative stress 
52
. This would suggest that also in the frail elderly the 
increase in spermidine is a response to reduced oxidative capacity and increase in oxidative 
stress.  
The level of carnosine is decreased in healthy older subjects in comparison to young subjects, 
and in frail in comparison to healthy older subjects. Carnosine is an abundant metabolite in 
muscle where it plays an important role in intracellular pH buffering 
53
. Carnosine has also 
been associated with chelation of metal ions and antioxidant activity 
54
. Furthermore, 
carnosine levels are higher in type II muscle fibers compared to type I. A likely explanation 
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for the significantly lower levels of carnosine in healthy and frail older subjects is therefore a 
decrease of the muscle fiber II/I ratio with respectively age and lack of exercise
55
. 
Several oxylipins derived from linoleic acid (LA) and α-linoleic acid (ALA) occur at higher 
levels in the muscle of the healthy older subjects compared to young subjects. On the other 
hand, levels of metabolites derived from the ∆-6 desaturase product dihomo-γ-linoleic acid 
(DGLA) are lower in healthy older subjects. We postulate that due to reduced ∆-6 desaturase 
activity linoleic acid and α-linoleic acid accumulate in the muscle of the healthy older 
subjects, whereas downstream ∆-6 desaturase product dihomo-γ-linoleic acid products are 
depleted 
56
.  
Effect of prolonged resistance-type exercise training 
We compared the effect of prolonged resistance-type exercise training in both healthy and 
frail older subjects on all measured metabolites using multilevel sPLS. There was a profound 
correlation between the adaptive response to training between the transcriptome and amino 
acids in the muscle metabolome (canonical correlations between 0.7 and 0.8). Particularly 
high correlations were observed between expression changes of extracellular matrix genes and 
amino acids. Although it is unlikely that there is a direct link between expression of these 
genes and levels of these metabolites, it does imply that these changes in amino acid levels are 
part of the adaptive response to resistance-type exercise training.  
At the metabolite level, the most striking effects of resistance-type exercise training in frail 
and healthy older subjects were observed for the C3 (propionyl) and C5 (isovaleryl) muscle 
acylcarnitines which are derived from branched chain amino acids. After training, the amino 
acid derived acylcarnitines showed a significant decrease both in the healthy and frail older 
subjects, accompanied by an increase of branched chain amino acids. A likely explanation is 
that the flux-determining mitochondrial branched chain α-keto acid hydrogenase (BCKDH) 
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complex 
57
 has a compromised response to prolonged resistance-type exercise training. As is 
schematically depicted in Figure 4-a, the BCKDH complex can respond to exercise via 
different mechanisms. PGC-1α is a known activator of BCKDH, but training did not have an 
effect on its gene expression in our study. Exercise is known to increase NAD
+
 levels 
45
 and 
could thus activate PGC-1α in a post-translational manner via SIRT1. Apparently this 
mechanism is also not activated by training in the older subjects. These effects are specific for 
branched chain amino acids oxidation and no significant effects on fatty acid derived 
acylcarnitines were found. A decrease in branched chain amino acids oxidation may stimulate 
mTOR related pathways activation and protein synthesis or attenuate muscle protein 
breakdown
58, 59
, which could be beneficial for older subjects. As this mechanism occurs at 
enzymatic level, the available metabolomics and transcriptomics data can however not 
confirm this hypothesis and in future studies proteomics analysis would be called for. 
 Correlation of plasma and muscle metabolome 
The weak correlations between plasma and muscle metabolite levels indicate that plasma 
levels only partially reflect muscle metabolism, even though skeletal muscle is one of the 
largest metabolically active tissues in the human body. This seems to suggest that these 
metabolites are also produced by other metabolic compartments. In a recent study, lack of 
correlation between acylcarnitine levels in plasma and tissues in mice was attributed to 
differences in turnover in plasma and muscle compartments, and contribution of other 
compartments than muscle to plasma acylcarnitine levels 
60
. The same rationale very likely 
also applies to amino acids involved in collagen metabolism (proline, 4-hydroxyproline), 
which can also be formed in bone. Adipose tissue is also a metabolically active compartment 
with regard to branched chain amino acids besides muscle 
61
, and this will likely weaken 
plasma-muscle level correlations. As a consequence, correlations between plasma metabolites 
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and muscle metabolites are too modest to support their use as direct read-outs of muscle 
metabolism 
62, 63
. 
 
Conclusion 
The major differences in muscle metabolome of healthy older and young subjects relate to 
mitochondrial function, fiber-type composition, and tissue turnover. Similar differences were 
observed when comparing frail older subjects to healthy older subjects. Prolonged resistance-
type exercise training resulted in a correlative adaptive response of amino acids and genes 
responsible for tissue remodeling. The effect of exercise on amino acid derived acylcarnitines 
in healthy and frail older subjects points towards decreased branched chain amino acids 
catabolism, likely due to attenuated activation of the flux-determining mitochondrial branched 
chain α-keto acid hydrogenase complex in older subjects. Only modest correlations between 
muscle metabolite and plasma levels were found, which prohibits the use of the latter as read-
outs of muscle metabolism. 
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TABLES 
Table 1.Characteristics of subjects of which skeletal muscle tissue biopsies were studied 
   Young Healthy older Frail older 
N (male / female) 30/0 47/19 25/18 
Age (years) 21.7 ± 2.5 71.7 ± 5.2 77.5 ± 8.0 
Height (m) 1.83 ± 0.06 1.72 ± 0.08 1.67 ± 0.09 
Weight (kg) 76.7 ± 11.8 75.9 ± 13.3 77.5 ± 11.1 
BMI
a
 (kg / m
2
) 22.6 ± 2.7 25.5 ± 3.0 27.5 ± 3.7 
Body Fat (%) 14.9 ± 4.9 24.5 ± 5.6 32.1 ± 8.8 
 Data was presented as mean ± SD. a: body mass index, 
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Table 2. Muscle metabolites that are significantly different between healthy older and young males 
a 
Metabolite  P-value 
FCb 
(Older/Young)   
TCA Cycle 
Succinic acid 0.02 0.76 
2-ketoglutaric acid 0.03 0.76 
Fumaric acid 0.04 0.82 
Lactic acid 0.05 0.69 
Energy 
ATP <0.01 0.75 
ADP 0.01 0.88 
Branched chain amino acids 
Valine <0.01 0.81 
Leucine <0.01 0.81 
Isoleucine 0.03 0.84 
Acylcarnitines 
Acetylcarnitine (C2) <0.01 0.49 
Malonylcarnitine (C3-DC) <0.01 0.46 
Intracellular buffering 
Carnosine <0.01 0.7 
Arginine, Proline Pathway 
Ornithine <0.01 1.55 
Arginine <0.01 1.34 
4-hydroxy-proline 0.01 0.69 
Proline 0.02 0.84 
Glycylglycine 0.05 0.87 
Methionine <0.01 0.8 
Other amino acids 
Lysine <0.01 1.44 
Aspartic acid <0.01 1.45 
Oxylipins 
LA (LOX) 
9-HODE <0.01 1.4 
13-HODE 0.01 1.37 
13-KODE 0.03 1.3 
LA(CYP450) 
  
9,10-EpOME 0.04 1.39 
ALA (LOX) 
9-HOTrE 0.01 1.71 
DGLA (LOX) 
15S-HETrE 0.02 0.83 
8-HETrE 0.03 0.85 
Aminobutyric acids 
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 β amino isobutyric acid <0.01 1.61 
α-aminobutyric acid 0.01 0.82 
   
a: Metabolites are presented that significantly (P-value =<0.05) differ between young  
and old subjects according to univariate ANOVA models.  b: Fold Change    
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Table 3.Muscle metabolites that are significantly different between frail and healthy older subjects.
a 
Metabolite Group  Sex  Interaction  FCb (Frail/Healthy)  
TCA Cycle 
Citric acid <0.01 NS c NS 0.54 
Acylcarnitines 
Isovalerylcarnitine (C5) <0.01 NS NS 0.42 
Octenoylcarnitine (C8) 0.03 0.03 NS 0.77 
Malonylcarnitine(C3-DC) 0.02 NS NS 0.77 
Carnitine (C0) 0.01 NS NS 0.75 
Intracellular buffering 
Carnosine 0.01 NS NS 0.8 
Oxylipins 
LA (CYP450) 
12,13DiHOME 0.04 NS 0.03 1.18 
DGLA (LOX) 
8HETrE 0.03 NS NS 0.81 
15SHETrE <0.01 NS NS 0.77 
Polyamine metabolism         
Spermidine 0.01 0.02 NS 1.24 
Spermine 0.04 NS NS 0.9 
Other amino acids  
Histidine <0.01 NS NS 0.79 
Asparagine 0.01 NS NS 0.81 
Taurine 0.01 NS NS 0.79 
Serine 0.01 NS NS 0.86 
Glycine 0.02 NS NS 0.81 
oacetylserine 0.02 NS NS 0.9 
Homoserine 0.02 NS NS 0.85 
Tyrosine 0.02 NS NS 0.83 
Tryptophan 0.02 0.04 NS 0.83 
Methionine 0.02 NS NS 0.83 
Glutamine 0.03 NS NS 0.82 
 Pyroglutamic acid 0.03 NS NS 0.83 
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Glutamic acid 0.04 NS NS 0.82 
Glycylglycine <0.01 NS NS 0.77 
Aminobutyric acids 
β amino isobutyric acid 0.05 NS NS 0.79 
a: Metabolites are presented that significantly (P-value =<0.05) differ between frail and healthy older subjects 
according to a univariate ANOVA models that accounted for Group effect (Frail vs. Healthy), Sex effect and 
Group-Sex interaction; Significance of Group (Frail vs. Healthy older subjects) effects and Group-Sex 
interactions has been indicated; b :fold change; c: not significant 
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Table 4. Training effect on muscle metabolites in healthy older subjects
 a
 
Metabolite Training FC(post/pre training)
b 
Pipecolic acid 0.002 1.64 
Isovalerylcarnitine (C5) 0.005 0.56 
Linoleylcarnitine (C18:2) 0.01 0.61 
Oleylcarnitine (C18:1) 0.01 0.7 
Propionylcarnitine (C3) 0.01 0.73 
Palmitoylcarnitine (C16) 0.02 0.75 
11.12.EpETrE 0.03 1.26 
Tetradecenoylcarnitine (C14:1 0.03 0.47 
AAAC
c 
 0.02 0.77 
FAAC
d
 NS 0.96 
a: Metabolites are presented that significantly (P-value =<0.05) differ pre- and 
 post-training in healthy older subjects according to univariate linear mixed models. 
We note that we constructed also linear mixed models that account for other factors  
and their interactions, but these were not found to be significant b: fold change,  
c,d: Single Value Decomposition (SVD) were calculated for amino acid and fatty acid  
acylcarnitines, denoted as AAAC and FAAC, respectively. 
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Table 5. Training effect on muscle metabolites in frail older subjects 
a 
Metabolite Training Supplement Sex Interaction FC(post/pre training)b 
Propionylcarnitine (C3) <0.01 NS
c
 NS NS 0.75 
Glucose <0.01 NS <0.01 NS 1.35 
Lactic acid 0.01 NS <0.01 NS 1.55 
Tetradecenoylcarnitine (C14:1) 0.03 NS NS NS 2.00 
Methionine 0.04 <0.01 NS NS 1.22 
Tryptophan 0.04 NS NS NS 1.21 
β Alanine 0.05 NS NS 0.01 0.92 
Isoleucine 0.05 <0.01 0.02 NS 1.21 
Myristoylcarnitine (C14) 0.05 NS NS NS 1.73 
AAACd 0.01 NS NS NS 0.76 
FAAC
e
 NS NS NS NS 1.95 
            
a: Metabolites are presented that significantly (P-value =<0.05) differ pre- and post-training in frail older 
subjects according to univariate linear mixed models that account for Supplement, Sex and (Training and 
Supplement) Interaction. We note that also linear mixed models were constructed that account for other 
interactions, but these were not found to be significant; b: fold change, c: Not Significant, d & e: Single Value 
Decomposition (SVD) were calculated for amino acid and fatty acid acylcarnitines (AAAC and FAAC, 
respectively).  
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FIGURE LEGENDS 
 
Figure 1. Principal component analysis (PCA) plot of biogenic amines detected in muscle 
biopsies. To visualize whether groups are significantly different from each other, confidence 
ellipses (95% Confidence Interval) were drawn around them. 
Figure 2. Correlation network of muscle metabolites and genes. Only significantly changed 
genes were selected (FDR<0.05). Metabolite canonical correlation cutoff <= 0.80. Circle: 
gene, rectangle: metabolite, Green : positive correlation. 
Figure 3. Pearson correlation heatmap of muscle to muscle metabolites (a), plasma to plasma 
metabolites (b), muscle to plasma metabolites (c). (d) Pearson correlation network of the most 
strongly correlated muscle and plasma metabolites. Red and blue indicate positive and 
negative correlations, respectively. Thick lines: correlation ~0.5, thin lines: 0.3 <correlation 
<0.5. Pink nodes: muscle tissue (T) metabolites and yellow nodes: plasma (P) metabolites, 
Figure 4. (a) Schematic representation of mitochondrial oxidation of free fatty acids (FFA) 
and branched chain amino acids (BCAA). Arrows indicate effect of prolonged resistance-type 
exercise training on older subjects (healthy and frail) on BCAA (increase) and acylcarnitines 
(decrease) as well as the proposed (dashed-arrows) downregulation of the branched chain α-
keto acid hydrogenase (BCKDH) complex. (b) Schematic representation of age-related NAD
+
 
dependent acetylation of PGC1α. Dashed arrows indicate NAD
+
 and SIRT1 dependent 
downregulation of PGC-1α and β-isoamino butyric acid (BAIBA). 
  
Page 31 of 38
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
32 
 
 
Figure 1. 
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Figure 2. 
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Figure 3.  
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Figure 4. 
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